Elanco Animal Health Incorporated Common Stock vs. Johnson & Johnson
ELAN
Elanco Animal Health Incorporated Common Stock
$23.15 -0.09%
VS JNJJohnson & Johnson
$269.47 -0.19%
Johnson & Johnson (JNJ) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| ELAN | JNJ | |
|---|---|---|
| Market Cap | $11.58 billion | $650.65 billion |
| Revenue (TTM) | $5.02 billion | $97.93 billion |
| Net Income (TTM) | $-199,000,000 | $21.04 billion |
JNJ leads on 3 of 3 size & scale factors.
Valuation
| ELAN | JNJ | |
|---|---|---|
| P/E Ratio | — | 31.26 |
| Price / Book | 1.76 | 7.66 |
| Price / Sales | 2.31 | 6.64 |
ELAN leads on 2 of 2 valuation factors.
Profitability
| ELAN | JNJ | |
|---|---|---|
| Net Margin | -3.96% | 21.48% |
| Return on Equity | -3.02% | 24.76% |
JNJ leads on 2 of 2 profitability factors.
Dividend
| ELAN | JNJ | |
|---|---|---|
| Dividend Yield | — | 1.99% |
| Payout Ratio | — | 62.18 |
ELAN and JNJ split the dividend factors evenly.
Risk & Sentiment
| ELAN | JNJ | |
|---|---|---|
| Short Interest | 0.50% | 0.67% |
ELAN leads on 1 of 1 risk & sentiment factors.
Dig deeper: ELAN overview, ELAN financials, JNJ overview, JNJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.